Related Experiment Video
Updated: May 11, 2026
11:38
A Live-cell Image-Based Machine Learning Strategy to Monitor Pluripotent Stem Cell Differentiation
Published on: October 4, 2024
A comment on pluripotent stem cells in next-generation biomedical theranostics
1Genome Institute of Singapore, Office of Strategic Alliances, 60 Biopolis Street, Singapore 138672, Singapore. rossbachm@gis.a-star.edu.sg
Current Molecular Medicine
|May 7, 2013
Summary
Advancements in genome-wide association studies (GWAS) and DNA sequencing, combined with induced pluripotent stem cells (iPSCs), offer new ways to understand diseases and develop personalized medicine. These technologies enable better drug screening and toxicity prediction for novel theranostics.
Area of Science:
- Genomics and Stem Cell Biology
- Translational Medicine
- Pharmacogenomics
Background:
- New DNA sequencing and genome-wide association studies (GWAS) enhance understanding of human pathologies.
- Induced pluripotent stem cells (iPSCs) are entering clinical research, enabling disease pathway investigation and biomarker identification.
Purpose of the Study:
- To review the application of pluripotent stem cells in generating next-generation theranostics.
- To discuss new perspectives on using iPSCs for modeling clinical diseases and drug development.
Main Methods:
- Integration of induced pluripotent stem cells (iPSCs) with next-generation sequencing (NGS) and GWAS technologies.
- Utilizing iPSC-derived cells for drug screening, toxicity prediction, and biomarker discovery.
- Employing integrative genomics and genetic approaches to elucidate gene regulatory pathways.
Main Results:
- iPSCs serve as a patient-specific model for studying disease mechanisms and drug responses.
- Combined iPSC, NGS, and GWAS approaches can predict adverse drug effects and toxicity.
- Pluripotent stem cells offer a platform for analyzing disease complexity at the molecular level.
Conclusions:
- iPSCs and NGS technologies are powerful tools for regenerative theranostics and understanding pathobiology.
- Reliable production of iPSCs meeting pharmaceutical standards is crucial for widespread adoption in drug development.
- These integrated approaches advance personalized medicine and the development of targeted therapies.
More Related Videos
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.